Early results of a novel weed management solution using two herbicides show promise. The first known use of stacked gene edited herbicide tolerant traits in an elite variety of rice to improve weed management. SAN DIEGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has positive initial field trial results of a novel weed management solution for rice farm ...

SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that the company will report second quarter 2024 financial results on Thursday, August 8, 2024. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Second Quarter 2024 Results Conferen ...

NEW YORK, July 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. On June 4, 2024, Bonitas Research ("Bonitas") issued a report alleging that it had "found no evidence that Cibus' gene-editing technology brings desirable new crops to market." Bonitas asserted that it had found "farmer complaints of lower crop yields ...

Core Insights - Cibus, Inc. has expanded its intellectual property coverage for 10 gene editing and trait families, enhancing its patent portfolio across multiple regions including Europe, Asia, Latin America, Canada, and the United States [2][3] - The company now holds rights to over 1,000 patents and applications, including core original gene editing patents in agriculture, which solidifies its position in the market [3][6] - Cibus focuses on developing complex gene-edited traits that address productivity and sustainability challenges for farmers, utilizing technologies such as TALEN and its Rapid Trait Development System (RTDS®) [7][8] Intellectual Property Expansion - The recent patent expansion includes traits like Pod Shatter Reduction, Herbicide Tolerance, High Fiber Wheat, and Improved Quality Alfalfa, which are crucial for the company's growth strategy [6][8] - The recognition from patent offices validates Cibus' expertise in developing gene-edited traits, which is foundational to its business model [3][8] Market Position and Strategy - Cibus operates as a technology company rather than a seed company, licensing its developed traits to seed companies for royalties on seed sales [8] - The company is advancing its pipeline of productivity traits, with initial traits for Pod Shatter Reduction and weed management already in commercial development with leading seed companies [8]

Cibus is a leader in the development of complex gene edited traits in plants like Pod Shatter Reduction in Canola and Herbicide Tolerance in Rice. The Company's plant trait intellectual property is developed using its Rapid Trait Development System (RTDS®) including Gene Repair Oligonucleotides (GRON) and Transcription activator-like effector nuclease (TALEN) technology. About Cibus without limitation, market conditions, failure to satisfy customary closing conditions and the risk factors and other matters ...

Core Viewpoint - Block & Leviton is investigating Cibus, Inc. for potential securities law violations following a report from Bonitas Research that raised concerns about the effectiveness of Cibus' gene-editing technology and its impact on crop yields [8]. Group 1: Investigation Details - Block & Leviton is looking into whether Cibus committed securities law violations and may file an action to recover losses for investors [5]. - Investors who have lost money in Cibus investments are encouraged to contact Block & Leviton for assistance [9]. - The investigation was prompted by allegations from Bonitas Research, which claimed that Cibus' technology does not deliver desirable new crops and highlighted farmer complaints regarding lower crop yields [8]. Group 2: Whistleblower Information - Individuals with non-public information about Cibus are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [3]. Group 3: Company Background - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].

Core Insights - Cibus has successfully edited its first Nutrient Use Efficiency (NUE) trait in Canola, marking a significant milestone in gene editing for major crops in North America [6][7] - The company aims to improve crop production efficiency by enhancing the absorption of soil-borne nutrients, thereby reducing fertilizer use without compromising yield [7][9] - Cibus utilizes its patented RTDS® technology platform, known as the Trait Machine™, to accelerate the development of complex traits compared to traditional breeding methods [4][8] Nutrient Use Efficiency (NUE) Development - The NUE trait is designed to enable lower fertilizer use while maintaining or improving expected crop yields, addressing the inefficiency of nitrogen absorption in plants [9] - Currently, only about one-third of applied nitrogen fertilizer is absorbed by plants, which limits biomass generation and grain yield [7] - The production of nitrogen fertilizer contributes to 3% of global CO2 emissions, and a 20% reduction in nitrogen fertilizer use could equate to removing 130 million cars from the road [7] Cibus' Technological Advancements - Cibus is a leader in next-generation gene-edited trait development, creating traits that are indistinguishable from those developed through traditional breeding [4] - The Trait Machine™ process allows for high-throughput gene editing, significantly changing the speed and scale of trait development [4][8] - The company has established a pipeline of advanced traits, including White Mold and HT2, alongside the newly developed NUE trait [2][8] Strategic Positioning and Partnerships - Through the merger with Calyxt, Cibus has solidified its position in gene editing and trait development for major crops, focusing on licensing traits to seed companies [8] - The company has developed multiple crop platforms, including Canola, Rice, and Wheat, and plans to complete its Soybean platform in 2024 [8] - Cibus emphasizes its capability to integrate third-party developed traits into its crop platforms, showcasing its versatility as a development partner [8]

[Click here for information about joining the class action] Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for th ...

Core Viewpoint - Cibus, Inc. has announced a registered direct offering of 1,298,040 shares of Class A Common Stock and warrants, aiming to raise approximately $13.0 million to fund the development of new seed traits and for general corporate purposes [1][6]. Group 1: Offering Details - The offering includes 1,298,040 shares of Class A Common Stock at a price of $10.00 per share for institutional investors and $10.20 for the CEO, Rory Riggs [1]. - The warrants are exercisable immediately at a price of $10.00 per share, with a different initial exercise price of $10.07 for Mr. Riggs, and will expire five years after issuance [1]. - The gross proceeds from the offering are expected to be approximately $13.0 million before deducting fees and expenses [6]. Group 2: Use of Proceeds - The net proceeds from the offering will be used to fund the development of new and existing seed traits, Trait Machine operations, and for working capital and general corporate purposes [6]. Group 3: Company Overview - Cibus is a leader in agricultural biotechnology, focusing on gene editing technologies to develop plant traits for major global crops such as canola, corn, rice, soybean, and wheat [8]. - The company is not a seed company but a technology company that licenses traits to seed companies in exchange for royalties [8]. - Cibus has developed a pipeline of five productivity traits, including Pod Shatter Reduction and Sclerotinia resistance, with some traits in commercial development with leading seed companies [8].

Core Viewpoint - Block & Leviton is investigating Cibus, Inc. for potential securities law violations following a report from Bonitas Research that raised concerns about the company's gene-editing technology and its impact on crop yields [5][9]. Group 1: Investigation Details - Block & Leviton is looking into allegations that Cibus' gene-editing technology does not deliver desirable new crops to market, with reports of farmer complaints regarding lower crop yields and lost revenues [5]. - The investigation is prompted by Bonitas Research's findings, which include examples of large seed manufacturers and distributors withdrawing from partnerships with Cibus [5]. Group 2: Investor Eligibility - Investors who have lost money on their Cibus investments may be eligible to participate in the investigation, regardless of whether they have sold their shares [6]. - Block & Leviton encourages affected investors to contact them for more information on potential recovery options [9]. Group 3: Whistleblower Information - Individuals with non-public information about Cibus are encouraged to assist in the investigation or report to the Securities Exchange Commission under the whistleblower program, which offers rewards of up to 30% of any successful recovery [3].